financetom
Business
financetom
/
Business
/
DHFL case: Auditor Grant Thornton unearths another fraudulent transaction of Rs 6,182 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DHFL case: Auditor Grant Thornton unearths another fraudulent transaction of Rs 6,182 cr
Feb 22, 2021 5:35 AM

Dewan Housing Finance Corporation (DHFL) on Monday said its transaction auditor, Grant Thornton, has reported another fraudulent transaction of Rs 6,182 crore in the company. The administrator of the company received an initial report from the professional agency appointed as the transaction auditor indicating that there are certain transactions which are ”undervalued, fraudulent and preferential in nature”, DHFL said in a regulatory filing.

”As per the transaction auditor report shared with the administrator, the monetary impact of the above transactions covered under the application amounts to Rs 5,381.90 crore towards the outstanding principal, Rs 589.36 crore towards accrued interest and Rs 210.85 crore towards notional loss of interest on account of charging lower rate of interest,” said the filing about the estimated impact on the company. Further, the estimated amount involved in this fraud transaction places the monetary impact at around Rs 6,182.11 crore (which includes Rs 210.85 crore as notional loss of interest), said the company.

According to the findings of Grant Thornton (GT), these transactions happened over a period of time. The management of DHFL is currently being run under an administrator appointed under the Insolvency and Bankruptcy Code after frauds were detected in the company.

The administrator later on appointed GT as the transaction auditor to conduct investigation of the affairs of the company. Basis the investigation and observations of the Transaction Auditor, the Administrator has filed an application before the Mumbai bench of the National Company Law Tribunal (NCLT) on February 20, 2021 in respect of disbursement made to certain entities as other large project loans, against Kapil Wadhawan, Dheeraj Wadhawan, Creatoz Builders Pvt Ltd, Ikshudip Fincap Pvt Ltd, Rite Developers Pvt Ltd and certain other entities.

DHFL said the application to NCLT has been filed against 33 respondents, including Kapil Wadhawan, Dheeraj Wadhawan, Creatoz Builders, Ikshudip Fincap, Rite Developers and certain other entities. It is to be noted that further filings may be undertaken, in due course, the company said.

The stock of DHFL was trading at Rs 18.05 apiece on BSE, down 4.75 percent from its previous close.

First Published:Feb 22, 2021 2:35 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hillman Q3 net sales rise 8%, beat estimates
Hillman Q3 net sales rise 8%, beat estimates
Nov 4, 2025
Overview * Hillman Q3 2025 net sales rise 8% to record $424.9 mln, beating analyst expectations * Adjusted EPS for Q3 2025 beats consensus, reaching $0.22 per share * Company repurchased 325.6 thousand shares, totaling $3.2 mln Outlook * Hillman maintains FY 2025 net sales guidance at $1.535 to $1.575 bln * Company raises FY 2025 adjusted EBITDA guidance to...
Nuvectis Pharma Q3 net loss widens
Nuvectis Pharma Q3 net loss widens
Nov 4, 2025
Overview * Nuvectis Q3 net loss widens to $7.5 mln, driven by milestone and study costs * Cash position improves to $35.4 mln, supported by public offering and ATM facility * NXP900 Phase 1b program initiated, showcasing therapeutic potential in advanced cancers Outlook * Cash runway expected to support operations into 3Q-2027 Result Drivers * Research and development expenses were...
Wingstop Q3 system-wide sales rise 10%, helped by new restaurants
Wingstop Q3 system-wide sales rise 10%, helped by new restaurants
Nov 4, 2025
Overview * Wingstop ( WING ) fiscal Q3 system-wide sales rise 10% to $1.4 bln * Adjusted EBITDA for fiscal Q3 grows 18.6% to $63.7 mln, highest quarter on record * Company opened 114 net new restaurants, achieving 19.3% net new unit growth Outlook * Wingstop ( WING ) revises 2025 domestic same store sales growth to decline 3%-4% *...
BRIEF-Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
BRIEF-Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Nov 4, 2025
Nov 4 (Reuters) - Evoke Pharma Inc ( EVOK ): * EVOKE PHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY QOL MEDICAL * EVOKE PHARMA INC ( EVOK ): PROPOSED DEAL FOR FOR $11.00 PER SHARE IN CASH AT CLOSING Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved